Investor Information
Latest News
US INVESTOR PRESENTATION 09-Feb-2010
BIONOMICS LIMITED BROADCAST 04-Feb-2010
POSITIVE NEW BNC210 DATA 02-Feb-2010
BNC105 US RENAL CANCER TRIAL INITIATED 27-Jan-2010
OPEN BRIEFING - BNC105 PHASE II TRIAL FOR MESOTHELIOMA 22-Dec-2009
APPOINTMENT OF CHIEF FINANCIAL OFFICER AND COMPANY SECRETARY 18-Dec-2009
BNO NOW DECEMBER 09 NEWSLETTER 14-Dec-2009
BIONOMICS 2009 AGM BROADCAST 06-Nov-2009
CHAIRMAN'S ADDRESS 04-Nov-2009
CEO'S ADDRESS 04-Nov-2009
NEW CHAIRMAN'S ADDRESS 04-Nov-2009
FIRST STAGE OF BNC210 CLINICAL TRIAL SUCCESSFULLY COMPLETED 27-Oct-2009
LATEST BNC210 DATA TO BE PRESENTED IN US 16-Oct-2009
SPP CLOSES OVERSUBSCRIBED 08-Oct-2009
INVITATION TO SHAREHOLDERS TO TOUR BIONOMICS FACILITY 08-Oct-2009
NOTICE OF ANNUAL GENERAL MEETING /PROXY FORM 02-Oct-2009
ANNUAL REPORT TO SHAREHOLDERS 2009 30-Sep-2009
BOARDROOM RADIO BROADCAST - BNO INVESTOR UPDATE SEPTEMBER 2009 18-Sep-2009
CEO OPEN BRIEFING 17-Sep-2009
2009 SHARE PURCHASE PLAN OFFER - ADDENDUM 17-Sep-2009
CAPITAL RAISING UPDATE - SHARE PURCHASE PLAN 11-Sep-2009
NOTICE OF EXTRAORDINARY GENERAL MEETING & PROXY FORM 10-Sep-2009
$15 MILLION CAPITAL RAISING 08-Sep-2009
INVESTOR UPDATE - SEPTEMBER 2009 08-Sep-2009
START-UP PLACEMENT 03-Sep-2009
APPENDIX 4E 28-Aug-2009
BNO JULY 2009 NEWSLETTER 27-Jul-2009
BIONOMICS TO UNDERTAKE US CLINICAL TRIAL OF BNC105 IN RENAL CELL CANCER 02-Jul-2009
OPEN BRIEFING - BNO CEO ON MILESTONES ACHIEVED 02-Jul-2009
BNO BROADCAST – HEALTHY INVESTMENT eCONFERENCE PRESENTATION 01-Jul-2009
PHASE I CLINICAL TRIAL OF BIONOMICS’ ANTI ANXIETY DRUG BNC210 INITIATED 25-Jun-2009
CANCER FIGHTING COMPOUND - BNC105 TO AIR ON ABC RADIO AUSTRALIA 15-Jun-2009
BOARDROOM RADIO BROADCAST - BNC210 APPROVED TO ENTER TRIAL 04-Jun-2009
INITIAL DATA FROM BNC105 PHASE I CLINICAL TRIAL PRESENTED 29-May-2009
OEN BRIEFING BNC105 INTERIM DATA 29-May-2009
BIONOMICS’ ANXIETY DRUG CANDIDATE APPROVED TO ENTER HUMAN CLINICAL TRIAL 21-May-2009
BNO - CEO PRESENTATION MAY 2009 05-May-2009
NEW BNC105 DATA PRESENTED AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE 22-Apr-2009
OPEN BRIEFING - NEW DATA ON BNC105 22-Apr-2009
BIONOMICS NAMED IN SMART 100 INDEX 15-Apr-2009
BIONOMICS APRIL 2009 NEWSLETTER 09-Apr-2009
BOARDROOM RADIO BROADCAST - HALF YEARLY REPORT 03-Mar-2009
KEY INSTITUTIONAL INVESTOR SUPPORTS BNO CAPITAL RAISING 10-Feb-2009
OPEN BRIEFING - CEO ON OPTION EXPIRY 05-Feb-2009
BNOOB OPTIONS EXERCISE 30-Jan-2009
INVESTOR PRESENTATION - JANUARY 2009 19-Jan-2009
OPEN BRIEFING - CEO UPDATE 15-Jan-2009
BIONOMICS NOW JANUARY NEWSLETTER 14-Jan-2009
BIONOMICS ANNOUNCES ADDITION TO BOARD 23-Dec-2008
BNOOB OPTIONS REMINDER 22-Dec-2008
BIONOMICS’ ANTI-ANXIETY CANDIDATE BNC210 SUCCESSFULLY COMPLETES SAFETY STUDIES 17-Dec-2008
OPTIONS UNDERWRITING 16-Dec-2008
OPEN BRIEFING - BNO CEO ON RECENT DEVELOPMENTS 12-Nov-2008
AGM BROADCAST 11-Nov-2008
AUSTIN HEALTH COMES ON BOARD BNC105 TRIAL 05-Nov-2008
BNC105 CLINICAL TRIAL UPDATE 16-Sep-2008
US AND EUROPEAN INVESTOR PRESENTATION 08-Sep-2008
BIONOMICS NOW SEPTEMBER NEWSLETTER 05-Sep-2008
BIONOMICS’ COMPOUND BNC210 DECREASES ANXIETY IN ANIMAL MODELS - LATEST DATA PRESENTED AT EUROPEAN CONFERENCE 01-Sep-2008
BIONOMICS' 2007/2008 PRELIMINARY FINAL RESULTS 22-Aug-2008
BIONOMICS EXTENDS CONTRACT OF CEO AND MANAGING DIRECTOR DEBORAH RATHJEN 08-Aug-2008
BNO AUDIO BROADCAST 17-Jul-2008
BIONOMICS COMPLETES GMP SYNTHESIS OF ANTI-ANXIETY DRUG BNC210 09-Jul-2008
BNO NEWSLETTER JULY 2008 30-Jun-2008
OPEN BRIEFING - BNO & MERCK SERONO DEVELOPMENT AGREEMENT 24-Jun-2008
MERCK SERONO AND BIONOMICS ANNOUNCE MULTIPLE SCLEROSIS DEVELOPMENT AND LICENSING AGREEMENT 19-Jun-2008
BIONOMICS AWARDS GMP MANUFACTURE CONTRACT FOR ANXIETY DRUG CANDIDATE BNC210 16-Apr-2008
BIONOMICS PRESENTS BNC105 DATA AT INTERNATIONAL CANCER CONFERENCE 14-Apr-2008
BNO NEWSLETTER APRIL 2008 02-Apr-2008
BIONOMICS ADVANCES ANTI-ANXIETY CANDIDATE BNC210 11-Mar-2008
BIONOMICS STRENGTHENS BOARD WITH NEW APPOINTMENT 28-Feb-2008
CEO ON BNC105 PHASE I CLINICAL TRIALS 27-Feb-2008
TREATMENT OF FIRST PATIENT IN PHASE I CLINICAL TRIAL OF BIONOMICS’ ANTI-CANCER DRUG BNC105 26-Feb-2008
BIONOMICS ACHIEVES US$1 MILLION MILESTONE PAYMENT FROM GENMAB 19-Feb-2008
BIONOMICS NOW NEWSLETTER 21-Jan-2008
BIONOMICS’ ANTI-CANCER COMPOUND GAINS IND APPROVAL 22-Nov-2007
CHAIRMAN AND CEO ADDRESS 07-Nov-2007
BIONOMICS ACHIEVES KEY MILESTONES 07-Nov-2007
OPEN BRIEFING - CEO ON PIPELINE DEVELOPMENT STATUS 07-Nov-2007
AGM BROADCAST 07-Nov-2007
LATEST DATA PRESENTED AT INTERNATIONAL CONFERENCE 05-Oct-2007
NEWSLETTER TO SHAREHOLDERS 14-Sep-2007
2006 / 2007 FINANCIAL RESULTS – VARIATION TO 4E 07-Sep-2007
BIONOMICS' 2006/2007 PRELIMINARY FINAL RESULTS 29-Aug-2007
BIONOMICS TO DEVELOP CANCER DRUG TARGET BNO69 WITH SUPPORT FROM THE CANCER THERAPEUTICS CRC 06-Aug-2007
IBRO 2007 CONFERENCE POSTER - BNC210 13-Jul-2007
IBRO 2007 CONFERENCE POSTER - Kv1.3 ION CHANNEL BLOCKERS 13-Jul-2007
BIONOMICS PRESENTS MULTIPLE SCLEROSIS AND ANXIETY DRUG DATA AT INTERNATIONAL CONFERENCE 13-Jul-2007
S708A PLACEMENT NOTICE 05-Jul-2007
BNOOA OPTION EXPIRY NOTICE 03-Jul-2007
AUDIO BROADCAST - BIONOMICS RAISES $10 MILLION IN PRIVATE PLACEMENT 21-Jun-2007
BIONOMICS RAISES $10 MILLION IN PRIVATE PLACEMENT 20-Jun-2007
BIONOMICS NEWSLETTER - JUNE 2007 12-Jun-2007
BIONOMICS’ VALIDATES THIRD CANCER APPLICATION FOR ANTI-CANCER COMPOUND BNC105 04-Jun-2007
OPEN BRIEFING - BIONOMICS PIPELINE UPDATE 04-Jun-2007
AUDIO BROADCAST - BIONOMICS MD - NEW DRUG CANDIDATE FOR ANXIETY 31-May-2007
BIONOMICS VALIDATES DRUG CANDIDATE FOR ANXIETY 29-May-2007
BIONOMICS COMPLETES GMP SYNTHESIS OF CANCER DRUG BNC105 ON TIME AND ON BUDGET 23-Apr-2007
OPEN BRIEFING - UPDATE ON BNC105 MILESTONES 23-Apr-2007
US$890 MILLION VDA DEAL INDICATES VALUE OF BIONOMICS’ BNC105 CANCER COMPOUND 23-Apr-2007
BIONOMICS ESTABLISHES NEW LABORATORY FACILITY TO ACCELERATE LATER STAGE DRUG DEVELOPMENT 19-Apr-2007
BIONOMICS PRESENTS CANCER DATA AT AACR CONFERENCE 17-Apr-2007
AACR Poster 17-Apr-2007
INVESTOR BRIEFING - EXCELLENCE IN BIOTECHNOLOGY & INVESTMENT CONFERENCE, SYDNEY 20-Mar-2007
M & A PRESENTATION – EXCELLENCE IN BIOTECHNOLOGY & INVESTMENT CONFERENCE, SYDNEY 20-Mar-2007
BIONOMICS SHAREHOLDER NEWSLETTER – MARCH 2007 13-Mar-2007
BIONOMICS TAKES KEY STEP FORWARD IN THE DEVELOPMENT OF ANTI-CANCER DRUG BNC105 21-Feb-2007
BIONOMICS MEETS WITH FDA IN US 17-Jan-2007
BIONOMICS TO BENEFIT FROM AU$37.60M FEDERAL CRC GRANT FOR CANCER DRUG DEVELOPMENT 02-Jan-2007
BIONOMICS NEWSLETTER 04-Dec-2006
BIONOMICS MD UPDATES OUTLOOK 16-Nov-2006
BIONOMICS DELIVERS ON MILESTONES FOR DRUG DISCOVERY PROGRAMS 09-Nov-2006
AGM CHAIRMAN AND CEO ADDRESSES 2006 09-Nov-2006
BNO AUDIO BROADCAST 09-Nov-2006
BNO AUDIO BROADCAST 25-Oct-2006
BIONOMICS AND SAFC PHARMA SIGN CONTRACT TO MANUFACTURE BNC105 25-Oct-2006
ASIA PACIFIC LIFE SCIENCES FORUM - PRESENTATION 12-Oct-2006
BIONOMICS TO CONDUCT BNC105 PHASE II TRIAL FOR MESOTHELIOMA TREATMENT 09-Feb-2010
